Assessment of What Patients and Healthcare Providers Value

Completed

• Conditions: Gastric Adenocarcinoma; Pancreatic Neuroendocrine Carcinoma; Pancreatic Adenocarcinoma
• Interventions: Other: Survey Administration

• Registration Number: NCT04483349
• Lead Sponsor: M.D. Anderson Cancer Center

Brief Summary

To assess the importance patients place on each of the attributes of value (i.e., outcomes, quality of life \[QOL\], cost, experience), and how these patients’ views differ depending on the stage of their therapy (pretreatment, preoperative therapy, post-operative, long-term surveillance, recurrence).

Detailed Description

PRIMARY OBJECTIVE:

I. To assess the importance patients place on each of the attributes of value (i.e., outcomes, quality of life \[QOL\], cost, experience).

SECONDARY OBJECTIVES:

I. To assess which attributes of value (i.e., outcomes, QOL, cost, experience) health care providers (i.e., physicians, nurses, administrators) feel are most important in health care delivery.

II. To assess how these patients' views differ depending on the stage of their therapy (pretreatment, preoperative therapy, post-operative, long-term surveillance, recurrence).

III. To assess how patients' view differ to health providers.

OUTLINE:

Patients and healthcare providers complete a survey over 10-15 minutes.

Study Timeline

• Study Start: 2020-06-11
• Study First Submitted: 2020-07-14
• Study First Submitted QC: 2020-07-21
• Study First Posted: 2020-07-23
• Status Verified: 2022-08
• Primary Completion: 2022-08-11
• Study Completion: 2022-08-11
• Last Update Submitted: 2022-08-30
• Last Update Posted: 2022-08-31

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 397

Inclusion Criteria

• Any patient who has been treated, or is anticipated to be treated, for potentially resectable, biopsy-proven pancreatic adenocarcinoma, pancreatic neuroendocrine malignancy, or gastric adenocarcinoma
• Providers involved in the care of gastric and pancreatic cancer patients. Providers will include non-collaborative surgical oncologists, medical oncologists, radiation oncologists, administrators, nurses, mid-level providers
• Able to understand the description of the study and willing to participate

Read More

Exclusion Criteria

• Inability to read and answer questions in English

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Observational (survey administration)	Survey Administration	Patients and healthcare providers complete a survey over 10-15 minutes.

Primary Outcome Measures

Name	Time	Method
Importance patients place on each of the attributes of value (i.e., outcomes, quality of life [QOL], cost, experience)	Survey completion up to 1 year	We will calculate the mean rank of patients yielding usable data and its corresponding 95% confidence interval. Patient characteristics and survey items will be summarized using descriptive statistics, including means, standard deviations (SDs), proportions, range, and 95% confidence intervals (CIs), etc.

Secondary Outcome Measures

Name	Time	Method
Most important attributes of value to healthcare providers	Survey completion up to 1 year	Provider characteristics and survey items will be summarized using descriptive statistics, including means, SDs, proportions, range, and 95% CIs, etc.
Importance care providers (i.e., physicians, nurses, administrators) place on each of the attributes of value (i.e., outcomes, quality of life [QOL], cost, experience)	Survey completion up to 1 year	Chi-square tests (or Fisher's exact test) will be used to compare the results between patients and providers.

Trial Locations

Locations (1)

M D Anderson Cancer Center; 🇺🇸 Houston, Texas, United States